Navigation Links
BioMarin Announces Fourth Quarter and Full Year 2010 Financial Results
Date:2/17/2011

lude Naglazyme® (galsulfase) for mucopolysaccharidosis VI (MPS VI), a product wholly developed and commercialized by BioMarin; Aldurazyme® (laronidase) for mucopolysaccharidosis I (MPS I), a product which BioMarin developed through a 50/50 joint venture with Genzyme Corporation; Kuvan® (sapropterin dihydrochloride) Tablets, for phenylketonuria (PKU), developed in partnership with Merck Serono, a division of Merck KGaA of Darmstadt, Germany; and Firdapse™ (amifampridine phosphate), which has been approved by the European Commission for the treatment of Lambert Eaton Myasthenic Syndrome (LEMS). Product candidates include GALNS (N-acetylgalactosamine 6-sulfatase), which is currently in Phase III clinical development for the treatment of MPS IVA, PEG-PAL (PEGylated recombinant phenylalanine ammonia lyase), which is currently in Phase II clinical development for the treatment of PKU, BMN-701, a novel fusion protein of insulin-like growth factor 2 and acid alpha glucosidase (IGF2-GAA), which is currently in Phase I/II clinical development for the treatment of Pompe disease, and BMN-673, a poly ADP-ribose polymerase (PARP) inhibitor, which is currently in Phase I/II clinical development for the treatment of genetically-defined cancers. For additional information, please visit www.BMRN.com. Information on BioMarin's website is not incorporated by reference into this press release.

Forward-Looking StatementThis press release contains forward-looking statements about the business prospects of BioMarin Pharmaceutical Inc., including, without limitation, statements about: the expectations of revenue and sales related to Naglazyme, Kuvan, Firdapse, and Aldurazyme; the financial performance of the BioMarin as a whole; the timing of BioMarin's clinical trials of GALNS, Firdapse, PEG-PAL, BMN-673, BMN-701 and other product candidates; the continued clinical development and commercialization of Aldurazyme, Naglazyme, K
'/>"/>

SOURCE BioMarin Pharmaceutical Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

Related medicine technology :

1. BioMarin Initiates Pivotal Phase 3 Trial for GALNS for the Treatment of MPS IVA
2. BioMarin to Host Fourth Quarter and Full Year 2010 Financial Results
3. BioMarin Initiates Phase 1/2 Trial for BMN 701 for the Treatment of Pompe Disease
4. BioMarin Initiates Phase 1/2 Trial for BMN 673 for the Treatment of Genetically-Defined Cancers
5. BioMarin to Present at the J.P. Morgan 29th Annual Healthcare Conference
6. BioMarin to Present at the Deutsche Bank 2010 BioFEST Conference
7. BioMarin Completes Partial Exchange of Convertible Notes Due 2013 for Common Stock
8. BioMarin Announces Third Quarter 2010 Financial Results
9. BioMarin to Host a Research and Development Day on October 19th
10. BioMarin Appoints William Young and Kenneth Bate to Its Board of Directors
11. BioMarin to Present at the UBS Global Life Sciences Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/22/2014)... YORK , Oct. 22, 2014 Sanomedics ... August 2014 report by Global Research & Data Services, ... per year from 2014 through 2018, as demand for ... States is the world,s largest market for ... with advanced thermometers is Sanomedics International Holdings, Inc. ...
(Date:10/22/2014)... 22, 2014  AcelRx Pharmaceuticals, Inc. (NASDAQ: ... the  IAP310 study have been published in ... peer-reviewed journal with broad, multidisciplinary readership. IAP310 was ... safety and efficacy of Zalviso, also referred to ... the treatment of post-operative pain in patients following ...
(Date:10/20/2014)... Calif. , Oct. 20, 2014  PneumRx, Inc. ... interventional pulmonology, today announced completion of enrollment in their ... RENEW Clinical Study is the FDA-approved IDE pivotal trial ... severe emphysema. It was anticipated that the ... February 2013, would take until the end of 2014 ...
Breaking Medicine Technology:Sanomedics International Holdings Analyst Report: Taking Some Heat by BrokerBank Securities, Inc. 2AcelRx Announces Publication of Zalviso Phase 3 Abdominal Trial Results 2PneumRx Completes RENEW Pivotal Trial Enrollment 2PneumRx Completes RENEW Pivotal Trial Enrollment 3
... SCOLR Pharma, Inc. (OTC Bulletin Board: SCLR ... & Company, a company providing complete support services to ... pharmaceutical companies, distributors and retailers that are interested in ... prescription pharmaceutical or nutritional products.   With ...
... Feb. 25, 2011 Pharmasset, Inc. (Nasdaq: VRUS ) ... be held March 1 - 3, 2011 at the Hilton New ... be held March 2 - 3, 2011 at the New York ... 31st Annual Healthcare Conference to be held March 7 - 9, ...
Cached Medicine Technology:SCOLR Pharma, Inc. Retains Nicholas Hall & Company 2Pharmasset to Present at Three Upcoming Investor Conferences 2Pharmasset to Present at Three Upcoming Investor Conferences 3
(Date:10/22/2014)... Lexington, Kentucky (PRWEB) October 22, 2014 ... an agreement that will change the current location of ... Road to South Limestone across from the University of ... be a state-of-the-art ambulatory care center, owned and operated ... meet the orthopaedic needs of children and their families ...
(Date:10/22/2014)... (PRWEB) October 22, 2014 During the ... fresh water supply runs dangerously low, Southern Oregon’s water ... Oregon’s rivers, despite the lowest mountain snow pack on ... late summer and early autumn.* That was the observation ... the new book “Hiking Southern Oregon,” during an interview ...
(Date:10/22/2014)... there are only 24 hours in a day, that doesn’t seem ... time within their busy schedules for exercise and fitness. Fortunately, one ... get in shape. Here are five ways you can reach your ... Up Your Commute , Consider riding a bike or taking the ... daily routine. If you must use your car to get to ...
(Date:10/22/2014)... HealthDay Reporter , TUESDAY, Oct. ... and length may be showing a genetic propensity for obesity ... genes have been linked to increased body fat, but the ... lean muscle, the researchers said. At 1 year, kids ... 2 and 3, however, these genes were linked to excessive ...
(Date:10/22/2014)... By Maureen Salamon ... -- A crucial part of conventional in vitro fertilization (IVF) ... can instead take place in a device inside the vagina, ... Colombia contend that the device, called an INVOcell, might sharply ... could also make the technology more accessible to those who ...
Breaking Medicine News(10 mins):Health News:Shriners Hospitals for Children - Lexington Announces Plan to Build New $47 Million Facility 2Health News:Shriners Hospitals for Children - Lexington Announces Plan to Build New $47 Million Facility 3Health News:Southern Oregon Is West’s Most Drought Proof Fresh Water Region Say Hiking Guide Authors 2Health News:Southern Oregon Is West’s Most Drought Proof Fresh Water Region Say Hiking Guide Authors 3Health News:Southern Oregon Is West’s Most Drought Proof Fresh Water Region Say Hiking Guide Authors 4Health News:HealthGuideMD Presents Ways to Improve Your Exercise and Fitness 2Health News:Tall, Heavy 1-Year-Olds May Be at Risk for Obesity Later, Study Finds 2Health News:Experimental Infertility Treatment Seems Effective, Cheaper 2Health News:Experimental Infertility Treatment Seems Effective, Cheaper 3Health News:Experimental Infertility Treatment Seems Effective, Cheaper 4
... still received high-quality care , WEDNESDAY, June 3 (HealthDay ... should reassure patients and the doctors who treat them. ... patients whose condition is complex may not get the ... Laura Peterson. "Doctors are concerned that under pay-for-performance there ...
... global leader in overseas health care facilitation, launches its online ... , The exclusive website is custom-built for existing and potential ... world seeking accessible and affordable first-rate health care solutions. ... more reachable and viable for consumers underlies the intuitive design ...
... Care Needs; Economic uncertainty and increased longevity add urgency , ... to live longer in retirement than past generations, and the ... has never been more critical. However, many people avoid bringing ... members, primarily because of a reluctance to accept what may ...
... study provides the first direct evidence that our mood literally ... suggesting that seeing the world through rose-coloured glasses is more ... change the way our visual cortex operates and how we ... psychology. "Specifically our study shows that when in a ...
... Football Hall-of-Famer Mike Ditka, one of the most popular figures ... of this month,s episode of Sharing Miracles -- ... and inspirational stories of real patients. Sharing Miracles ... nationwide. Known for his flamboyant style, "Da Coach" is ...
... : The National Infertility Association honored Reproductive Medicine Associates ... with The 2009 Friends of RESOLVE Award at their Annual Night ... program recognizes individuals and practices who have been devoted to assisting ... RESOLVE in helping the 7.3 million people in the U.S. build ...
Cached Medicine News:Health News:Pay-for-Performance Doesn't Shortchange Patients 2Health News:Pay-for-Performance Doesn't Shortchange Patients 3Health News:Veiovis Launches Medical Travel Web Portal 2Health News:Veiovis Launches Medical Travel Web Portal 3Health News:Video: Plan for Long Term Care Before the Crisis Hits 2Health News:Video: Plan for Long Term Care Before the Crisis Hits 3Health News:Video: Plan for Long Term Care Before the Crisis Hits 4Health News:People who wear rose-colored glasses see more, University of Toronto study shows 2Health News:'Sharing Miracles' Television Program to Feature Super Bowl Winner, Hall-of-Famer Mike Ditka 2Health News:'Sharing Miracles' Television Program to Feature Super Bowl Winner, Hall-of-Famer Mike Ditka 3Health News:'Sharing Miracles' Television Program to Feature Super Bowl Winner, Hall-of-Famer Mike Ditka 4Health News:'Sharing Miracles' Television Program to Feature Super Bowl Winner, Hall-of-Famer Mike Ditka 5Health News:'Sharing Miracles' Television Program to Feature Super Bowl Winner, Hall-of-Famer Mike Ditka 6Health News:'Sharing Miracles' Television Program to Feature Super Bowl Winner, Hall-of-Famer Mike Ditka 7Health News:'Sharing Miracles' Television Program to Feature Super Bowl Winner, Hall-of-Famer Mike Ditka 8Health News:National Infertility Organization Honors RMA of New York for Community Support 2
... of macular health. Snellen charts ... 20/20). Easy to mount on ... performed in a few minutes. ... patients. Retinal vision testing without ...
Non-mydriatic stereo fundus camera for glaucoma detection at early stage....
Eye Q SuperLite is ideal for color and red-free imaging used in general clinical and optometric casework such as anterior segmenting and diabetic screening....
The Genesis Camera meets the needs of those with specific requirements that cannot be met by a conventional 'chinrest' type camera....
Medicine Products: